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ChaperoneThroughout evolution, all organisms have harnessed the redox properties of copper (Cu) and iron (Fe) as a
cofactor or structural determinant of proteins that perform critical functions in biology. At its most sobering
stance to Earth's biome, Cu biochemistry allows photosynthetic organisms to harness solar energy and con-
vert it into the organic energy that sustains the existence of all nonphotosynthetic life forms. The conversion
of organic energy, in the form of nutrients that include carbohydrates, amino acids and fatty acids, is subse-
quently released during cellular respiration, itself a Cu-dependent process, and stored as ATP that is used to
drive a myriad of critical biological processes such as enzyme-catalyzed biosynthetic processes, transport of
cargo around cells and across membranes, and protein degradation. The life-supporting properties of Cu incur
a signiﬁcant challenge to cells that must not only exquisitely balance intracellular Cu concentrations, but also
chaperone this redox-active metal from its point of cellular entry to its ultimate destination so as to avert the
potential for inappropriate biochemical interactions or generation of damaging reactive oxidative species
(ROS). In this review we chart the travels of Cu from the extracellular milieu of fungal and mammalian
cells, its path within the cytosol as inferred by the proteins and ligands that escort and deliver Cu to intracel-
lular organelles and protein targets, and its journey throughout the body of mammals. This article is part of a
Special Issue entitled: Cell Biology of Metals.
© 2012 Elsevier B.V. All rights reserved.1. Copper awareness at a cellular level: yeast as a model system
All organisms have evolved mechanisms to respond to extracellu-
lar stimuli that allow for the homeostatic acquisition of nutrients to
ensure cellular function, proliferation or differentiation, for evasion
or adaptation to environmental stresses that compromise viability
or for defense against competing organisms that represent an obsta-
cle to sustained survival. These response mechanisms rely on the pre-
cise integration of extracellular cues with signal transduction
cascades that initiate regulated responses to the perceived stimulus.
The strict requirement to maintain cellular Cu levels within the
threshold of adequacy to meet metabolic demand, and below those
that exceed the capacity of the cell to appropriately bind and store
Cu to avert cytotoxicity, demands a sensitive awareness of the dy-
namic ﬂuctuations in extracellular and intracellular Cu.
The model eukaryote, Saccharomyces cerevisiae, has proven an in-
valuable tool in understanding fundamental aspects of cell biology
that are conserved from yeast to mammals (Fig. 1). In this respect, ad-
vances in the identiﬁcation of proteins and ligands involved in yeast
Cu metabolism have provided critical insights into the identiﬁcationiology of Metals.
).
l rights reserved.and characterization of orthologous players that similarly operate in
mammalian cells, many of which, when mutated, lead to human dis-
ease. The striking functional conservation shared by yeast and mam-
malian Cu handling, Cu-dependent and Cu-storage proteins has
permitted the characterization of mammalian orthologues and
disease-associated mutations in the facile and genetically-tractable
yeast S. cerevisiae, underscoring the continued importance of this
model in advancing knowledge on Cu metabolism as it relates to
human health and disease.
Awareness of cellular Cu status in the yeast S. cerevisiae is, in part, ac-
complished by the reciprocal activities of two nuclear Cu-binding tran-
scription factors, Ace1 andMac1 [1–4]. As cells undergo a shift from Cu-
deﬁcient (or Cu-adequate) to high extracellular Cu bioavailability
(>1 μM), nuclear inactive, apo-Ace1 undergoes a conformational
change elicited as a result of the formation of a tetra-copper-thiolate
cluster within its amino-terminal DNA binding domain. Activated
Ace1 is then competent to bind to a speciﬁc cis-element (TX3GCTG)
within the promoter of target genes that include CUP1 and CRS5, encod-
ing the Cu-binding cysteine-rich metallothioneins (MTs) critical for
buffering intracellular Cu, as well as SOD1 encoding Cu, Zn superoxide
dismutase, that, in addition to its role in ROS detoxiﬁcation, endows
cells with enhanced ability to maintain a safe reservoir of intracellular
ligand-bound Cu [5]. In addition to enhanced expression of Cu detoxiﬁ-
cation genes, FET3 and FTR1 encoding the ferroxidase and ferrous iron
(Fe) permease, respectively, involved in elemental Fe uptake, are simi-
larly indirectly induced by the Fe-responsive transcription factor Aft1,
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sis under high Cu conditions [6]. Given the role of Fe-dependent catalase
in decomposing H2O2, one possibility is an enhanced requirement for
this co-factor in mounting a response to increased oxidative burden to
match ROS disproportionation to H2O2 catalyzed by Cu,Zn Sod1.
Cellular Cu satiety maintains Mac1 in an inactive state, potentially
through the coordination of up to 8 Cu ions by 2 cysteine-rich do-
mains within the transactivation domain at the carboxyl-terminus
of the protein, promoting an intra-molecular interaction with the
amino-terminal DNA-binding domain [7,8]. As a result of Cu binding
to Mac1, DNA binding to Cu-responsive cis-elements (CuREs;
TTTGC(T/G)C(A/G)) is mitigated, leading to diminished expression
of target genes that include the high afﬁnity Cu transporters CTR1
and CTR3, as well as the cell surface ferroreductases encoded by
FRE1 and FRE7 [9–12]. Deletion of Mac1 abrogates growth on non-
fermentable carbon sources, due to the absolute requirement for Cu
as a co-factor in the mitochondrial electron transport chain, impairs
Sod1 activity and compromises growth under Fe deﬁciency due to
the inability to metallate the Fet3 ferroxidase essential for high afﬁn-
ity reductive Fe2+ assimilation.
The strikingly antagonistic role of bound Cu on Ace1 and Mac1 ac-
tivities, in addition to the estimated intracellular free [Cu+] of ap-
proximately 10−18 M [13], suggests a complementary afﬁnity of
each transcription factor for Cu binding such that the range of activa-
tion of one shares little or no overlap with that of the other. This no-
tion is supported by recent studies that determined the Cu binding
constants for Ace1 and Mac1 using a FRET-based reporter system
that exploits the intra-molecular conformational changes that ensue
upon Cu binding to the cysteine-rich domains of the proteins [14].
The calculated dissociation constants revealed a higher afﬁnity of
Mac1 for Cu+ (Kd of approximately 9.7×10−20 M) when compared
to that of Ace1 (Kd of approximately 4.7×10−18 M) consistent not
only with apo-Mac1 binding to the promoters of genes involved in
high afﬁnity Cu uptake under conditions of Cu deﬁciency but also at
cellular Cu concentrations' orders of magnitude below the binding af-
ﬁnity of Ace1 for Cu+.
The constitutive nuclear localization of the Cu-sensing transcrip-
tional regulators Ace1 and Mac1 predicts the existence of a kinetically
labile Cu pool within the nucleus yet, in contrast to the existing body
of knowledge on the routing of Cu by cytosolic chaperones and trans-
porters between the secretory compartment, vacuole and mitochon-
dria, the nature or mechanism of Cu transport into the nucleus is
not well understood. Although a reactive pool of Cu+–GSH is
known to exist in the nucleus [15], over-expression of the Crs5 metal-
lothionein in this subcellular compartment does not compromise
Mac1 Cu-responsive regulation [1], indicative of the inability of this
labile nuclear Cu pool to promote Mac1 metallation. Furthermore,
Cu delivery to the nucleus does not require de novo protein synthesis
as evidenced by efﬁcient Cu-responsive Ace1 and Mac1 activities in
cycloheximide-treated cells [1]. Consistent with this observation
and perhaps providing further insights into the mechanism of Cu ac-
cumulation into the nucleus, recent studies suggest a role of Sod1 in
Mac1 activation under Cu deﬁciency [16]. Similar to previous obser-
vations in mammalian cells [17], these studies revealed that yeast
Cu chaperone for Sod1 (Ccs1) and Sod1 are partially localized to the
nucleus. Moreover, both Cu-binding proteins are required for robust
activation of Mac1-dependent gene expression. Furthermore, the re-
quirement for Ccs1 appears to be limited to its role in delivering Cu
to Sod1 since the expression of Caenorhabditis elegans Sod1, that ac-
quires Cu independently of Ccs1 (CCS1 is not encoded in the genome
of C. elegans), is fully capable of activating Mac1 in a ccs1Δ strain. Al-
though the mechanism of Sod1 function in Mac1 activation is unclear,
both Sod1 catalytic activity as well as its nuclear localization are re-
quired for this process which is unaffected by the levels of intracellu-
lar superoxide. It is possible that the disproportionation of superoxide
into H2O2 by Sod1 generates a signal or is required as a reactant forMac1 activation. It would be interesting to over-express catalase in
the nucleus to evaluate the effects of enzymatic decomposition of
H2O2 on Sod1-mediated Mac1 activation under Cu deﬁciency.
Early studies identiﬁed an orthologue of Ace1 in Candida glabrata,
a phylogenetically close relative of the Saccharomycetes and an in-
creasingly relevant human fungal pathogen. Amt1 (Activator of MT
transcription 1) was originally isolated as a genomic DNA fragment
that conferred robust reporter activity and a Cu-resistance growth
phenotype when episomally-expressed in a S. cerevisiae ace1Δcup1Δ
strain harboring a genomic copy of the C. glabrata MT1 gene and an
MT1 promoter-driven reporter. [18]. Sequencing of the AMT1 gene
revealed an encoded polypeptide with striking similarities to the
amino terminus of Ace1 encompassing the Cu-activated DBD, includ-
ing 11 cysteine residues the ﬁrst 7 being exactly conserved between
the 2 proteins, as well as a corresponding enrichment of acidic resi-
dues that comprise the Ace1 trans-activation domain at the carboxyl
terminus. Deletion of AMT1 abolishes the growth of C. glabrata under
high exogenous Cu conditions due to the inability of cells to activate
MT gene expression [19]. Despite the structural and functional simi-
larities between Ace1 and Amt1, their regulation at the level of tran-
scription is distinct, with Ace1 showing Cu-independent constitutive
gene expression while Amt1 auto-activates its own transcription in
response to elevated Cu, correlating with an accumulation in mRNA
and protein levels required for resistance to Cu toxicity [20,21]. At
present, it is not known whether C. glabrata encodes an orthologue
for Mac1 but the high degree of phylogenetic and syntenic similarity
between these two species would certainly support the notion that
this may be the case. Indeed, perusal of the C. glabrata genome (Gen-
olevures) for a Mac1 orthologue reveals an ORF (CAGL0M07590g)
with similarity to and in gene synteny with S. cerevisiae MAC1
(Gene Order Browser). Given the relevance of C. glabrata in human
infectious disease as well as recent evidence for the use of Cu as a
microbiocidal mechanism employed by mammalian immune cells
[22], it would be exciting to begin to characterize Mac1 in this patho-
genic fungus.
Despite S. cerevisiae serving as one of the most valuable model eu-
karyotes to date, the existence of two Cu-sensing transcriptional reg-
ulators that, together, sense extremes in Cu availability is not a
widespread feature among fungal species. Of the phylogenetically
more distant fungi to S. cerevisiae studied, most also encode a Cu-
sensing transcription factor with functional similarity to Mac1 but ap-
pear to lack a distinct Ace1 counterpart. Curiously, both Schizosac-
charomyces pombe and the opportunistic pathogen Cryptococcus
neoformans seem to have evolved a single regulator with striking sim-
ilarities to both Mac1 and Ace1. In the ﬁssion yeast, S. pombe, the nu-
clear transcription factor Cuf1 (Cu factor 1) activates the expression
of genes involved in high afﬁnity Cu uptake under Cu deﬁciency
[23–25], akin to Mac1, as well as that of the vacuolar Cu exporter
CTR6, an orthologue of CTR2 in S. cerevisiae that is not regulated by
Cu but rather by Fe availability [26]. The amino-terminal 63 amino
acids of Cuf1 exhibit 51% identity to the corresponding region of S.
cerevisiae Ace1 (and 45% identity to Amt1), a region that includes
the Zn coordination domain responsible for DNA binding in Ace1
and Mac1, as well as extended homology to the Cu-binding domain
responsible for Ace1 Cu-inducible DNA binding to target gene pro-
moters. Heterologous Cuf1 expression in an ace1Δ strain can partially
complement growth in high Cu but does not substitute for the activity
of Mac1 in S. cerevisiae despite displaying high identity to the Cu-
sensing domain of Mac1 in the carboxyl terminus, indicating a critical
role in Cu uptake but not in its detoxiﬁcation [24]. Deletion of cuf1+
generates many of the phenotypes observed in themac1Δmutant, in-
cluding impaired respiratory growth, diminished Sod1 activity and
inability to grow under low Fe bioavailability. Interestingly, and in
contrast to Mac1, under low Cu availability Cuf1 represses several
genes encoding components of high afﬁnity reductive Fe uptake, in-
cluding frp1+, which encodes a metalloreductase, and the ﬁp1+/ﬁo+
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Fe via tandemly repeated cis-elements similar in sequence to the
CuREs found in the promoters of CTR1, CTR3, FRE1, FRE7 and FET3 S.
cerevisiae genes. Given the critical role of Cu in high afﬁnity Fe uptake
as well as in Sod1-mediated ROS detoxiﬁcation, it is perhaps not sur-
prising that cells undergoing Cu starvation actively down-regulate Fe
transport mechanisms that would be compromised in activity and
would furthermore promote the inﬂux of a redox active metal
under conditions of compromised antioxidant function.
C. neoformans Cuf1, while sharing signiﬁcant similarity to its S.
pombe counterpart, both at the level of protein structure and its activ-
ity in orchestrating the cellular response to Cu deﬁciency, has the
added functional attributes of S. cerevisiaeAce1 inmounting a cytopro-
tective response to Cu toxicity [27–29]. As expected, the cuf1Δ strain is
unable to grow under Cu deﬁcient conditions even in the presence of
glucose unless supplemented with exogenous Cu, underscoring the
preference of this fungal pathogen for respiratory over fermentative
growth. This growth phenotype results from the inability of the
cuf1Δ mutant to activate the expression of the high afﬁnity Cu trans-
porters CTR4 and CTR1, that in addition to catering for the demand of
Cu-dependent enzymes involved in mitochondrial respiration and
ROS detoxiﬁcation, supply this essential co-factor to the polyphenolic
oxidase, laccase, involved in melanin synthesis and a critical virulence
determinant in this organism [27,28]. Analogous to that observed in S.
cerevisiaeMac1-deleted strains, cuf1Δ cells are hyper-sensitive to oxi-
dative stress due to decreased Cu availability for incorporation into
Sod1 as well as diminished activity of the Fe-dependent enzyme cata-
lase, due to secondary Fe deﬁciency [29]. In contrast to S. pombe Cuf1,
the C. neoformans orthologue is critically required for resistance to Cu
toxicity and the cuf1Δ strain displays severe growth impairment under
elevated exogenous Cu, likely due to failure to induce the expression of
MT-encoding genes and perhaps other genes [28,29].
The existence of two dedicated regulators of Cu homeostasis in S.
cerevisiae and close phylogenetic relatives, which are functionally
replaced by a single regulator in more distantly-related fungal
species, begs the question whether this results from neo-
functionalization of an ancestral gene in species that underwent
whole genome duplication (WGD) [30]. Alternatively, both genes
may have been present in a common ancestor and have been subse-
quently lost or a chimeric protein generated through recombination
events. Inspection of synteny at the S. cerevisiae MAC1 and ACE1 loci
across several yeast genomes reveals orthologues of both genes in
pre-WGD genomes [31], arguing for genetic loss in species harboring
a single Cu-sensing regulator rather than neo-functionalization of a
duplicated ancestral gene.
1.1. Enter copper
As an essential yet toxic trace element, cellular Cu acquisition, han-
dling and storage must be rigorously governed. In the aerobic environ-
ment, Cu is predominantly present in its oxidized cupric form (Cu2+).
The dynamic bioavailability of Cu, as a function of extracellular pH, ox-
ygenation, changes inwater saturation or as a result of human-imposed
interventions such as the use of copper-based fungicides, poses a chal-
lenge in articulating a graded response to cellular demand. This is in
large part accomplished by the integration of Cu sensing mechanisms
with the regulation of high afﬁnity Cu transporters, intracellular buffer-
ing and sequestration mechanisms. The common theme, therefore, is
that mechanisms of high afﬁnity Cu acquisition are activated only
under conditions where environmental levels of Cu availability fall
below the binding afﬁnity of low afﬁnity metal transporters constitu-
tively expressed at the cell surface. In S. cerevisiae growing under condi-
tions of Cu adequacy, the activities of the Fe2+ transporter Fet4 and the
Smf (Suppressor of mitochondrial function) family of divalent metal
transporters orthologous to the NRAMP (Natural Resistance-
Associated Macrophage Protein) family of mammalian metalpermeases, fulﬁll the cellular demand for Fe, Cu, Mn and Zn [32,33]
Liu, 1999). Smf transporters are similarly present in several yeast spe-
cies including C. glabrata, S. pombe (Pdt1), C. neoformans and C. albicans.
However, when bioavailable Cu concentrations fall below the Km for
transport by Smf transporters (approximately 25–50 μM Cu), the ex-
pression of cell surface metalloreductases, required to reduce Cu2+,
and high afﬁnity Cu+ transporters (Km for Cu approximately 1–5 μM)
is activated by theMac1 and Cuf1 transcription factors leading to the ac-
cumulation of Ctr (Cu transporter) and Fre (ferro-reductase) proteins at
the plasma and vacuolar membranes, that together drive the concerted
mobilization of this metal from environmental sources as well as intra-
cellular stores. Copper uptake by the fungal Ctr proteins requires its
prior reduction from Cu2+ to Cu+. This is accomplished by cell surface
metalloreductases encoded by the FRE1 and FRE7 genes in S. cerevisiae
whose expression, under Cu deﬁciency, is regulated by Mac1
[9,10,34]. Analyses of genome-wide transcriptional responses to altered
Cu availability in S. pombe and C. neoformans reveal conserved regula-
tion of core Cu-responsive genes despite signiﬁcant evolutionary diver-
gence between these three yeast species [28,35].
The Ctr proteins are ubiquitous among all eukaryotes evaluated
and typically harbor three transmembrane domains (TM), multiple
potential Cu-binding ligands (methionine and histidine) along the
extracellular amino terminus and at the extracellular boundary of
TM2, as well as in the cytosolic carboxyl terminus. The Cu+ transport
function requires Ctr multimerization that results in the formation of
a Cu-permeable pore through which Cu+ is ferried in a series of puta-
tive exchange reactions between Cu-binding amino acid residues of
TM2 that line the interface of the trimer pore [36,37]. Unlike Cu+
transport by the P-type ATPase Ccc2 discussed below, Ctr activity is
not dependent on ATP hydrolysis, thus the mechanistic understand-
ing of how Cu+ traverses through the Ctr pore remains to be fully
deciphered. However, recent insights into the 3D structure of
human Ctr1 revealed a homo-trimeric complex arranged in a tail-
to-tail orientation in which the carboxy-termini face each other with-
in the cytosol, generating a cone-like pore that is narrow at the extra-
cellular face (approximately 8 Å across) and wide at the intracellular
aqueous exit (approximately 22 Å across) [37]. Additionally, the posi-
tion of the conserved M–X3–M Cu-binding motif on TM2 along the
pore interface of the symmetric Ctr1 trimer, relative to the regional
intra- and inter-monomeric packing of the membrane-spanning do-
mains, suggests that Cu+ exchange reactions between neighboring
methionines induce conformational changes responsible for con-
trolled conduction of the metal ion from the extracellular entry
point to the HCH-motif near the carboxyl terminus of the protein.
The higher stability of Cu+–cysteine interactions when compared to
those between Cu+–methionine, would thus favor cation enrichment
(in the form of a thermodynamic sink) at the wider aqueous intracel-
lular exit, thereby obviating the energetic requirement for ATP hydro-
lysis to drive Cu transport.
Although the Ctr proteins exhibit functional and topological con-
servation from yeast to mammals, sequence homology along the pro-
tein length is unimpressive, particularly outside of the highly
conserved methionine-rich (Mets) Cu-coordinating motifs. Notwith-
standing, human Ctr1 can functionally complement for the loss of
Ctr1 and Ctr3 in S. cerevisiae [38] and recent studies evidence an over-
all common membrane organization shared by the two most
distantly-related orthologues, S. cerevisiae Ctr3 and human Ctr1. Dif-
ferences in non-homologous regions between these proteins could
be accommodated by an adaptor function of TM1 that allows evolu-
tionarily distant Ctr proteins to adopt largely analogous higher-
order protein structures [39]. Some eukaryotic cells express multiple
Ctr proteins. In S. cerevisiae, Ctr1 and Ctr3 localize to the plasma
membrane whereas Ctr2 is present on the vacuolar membrane and
transports lumenal Cu stores into the cytosol. S. pombe also expresses
two cell surface Ctr proteins, Ctr4 and Ctr5, but in contrast to that ob-
served in S. cerevisiae and C. neoformans, functional Cu transporter
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of 2 Ctr4 molecules to 1 Ctr5 molecule [40]. The contribution of each
protein to the function of the heterotrimer was recently addressed
where it was found that a single Ctr4- or Ctr5-derived Mets-motif-
containing amino-terminal domain is required for Cu transport activ-
ity [41]. Furthermore, Ctr4–Ctr5 assembly and trafﬁcking to the plas-
ma membrane is dependent on heterotrimer formation, since in the
absence of either counterpart Ctr4 and Ctr5 fail to accumulate at the
cell surface. Recently, a second C. neoformans cell surface Ctr protein,
in addition to Ctr4, was identiﬁed, with high phylogenetic relation to
S. cerevisiae Ctr1 [28]. Unlike the seemingly redundant functions of
Ctr1 and Ctr3 in bakers yeast, deletion of C. neoformans Ctr1 leads to
a dramatic elevation in CTR4 mRNA expression, indicative of cellular
Cu deﬁciency in the mutant, whereas an analogous effect on C. neofor-
mans CTR1mRNA levels was not observed in the absence of CTR4. This
would suggest that in C. neoformans Ctr1 plays a primary role in high
afﬁnity Cu transport under standard laboratory growth conditions
and that Ctr4 may function predominantly under conditions of more
severe Cu deﬁciency.
While much is known regarding the acquisition and intracellular
distribution of Cu in mitotically-dividing cells, Cu metabolism during
developmental processes such as meiosis has not been investigated in
detail. It is widely accepted that conditions of nutrient starvation, no-
tably that of nitrogen sources, induce meiotic differentiation among
fungal species. In an elegant study by Beaudoin et al. [42], Cu deﬁcien-
cy was shown to induce S. pombe meiotic arrest and meiosis-speciﬁc
elevation of mfc1+ expression, encoding a novel Cu transporter be-
longing to the major facilitator superfamily. Mfc1 harbors 4 Mets mo-
tifs and is enriched for methionine and cysteine residues along the
protein length. Strikingly, while ctr4+ expression is induced in a
Cuf1-dependent manner under meiosis, albeit at signiﬁcantly lower
levels when compared to its induction in cells undergoing mitotic
cell division, mfc1+ expression during mitosis is undetectable and
its expression is Cuf1-independent during meiosis. Curiously,
zym1+, encoding a putative MT or cytosolic metallocarrier in S.
pombe, and not induced under high Cu conditions but rather by ele-
vated Zn or Cd concentrations, shows an almost 3-fold elevation in
mRNA levels in Cu-deﬁcient meiotic cells (Borrelly [42,43]. It would
be interesting to evaluate whether this represents impaired Zn ho-
meostasis in meiotically-dividing Cu deﬁcient cells or a meiosis-
speciﬁc Cu homeostasis activity. Functional studies in an S. pombe
ctr4Δctr5Δ double mutant in which mfc1+ expression was placed
under the control of the cuf1+ promoter demonstrate that Mfc1 res-
cues the respiratory growth defect of this mutant strain on non-
fermentable carbon sources, with a predicted afﬁnity for Cu in the
very lowmicromolar range but below that of the Ctr4–Ctr5 transport-
er complex. During meiosis, Mfc1 localizes to the forespore mem-
brane where it presumably delivers Cu to the forespore where it
may be used as a cofactor for Cu-dependent enzymes critical for
spore formation, maturation and release. Given the conservation be-
tween S. pombemfc1 protein and proteins found in higher eukaryotes
including mammals, the discovery of Mcf1 sets the stage for the iden-
tiﬁcation of novel Cu transporters, and Cu-dependent proteins, that
may operate in the germ line and in stem cell differentiation.
1.2. Intracellular copper relay
The recruitment of Cu into cells demands the concomitant imple-
mentation of active measures for relaying this redox-active ion to its
target proteins or subcellular compartments in a controlled fashion.
The accepted observation, based on several independent studies,
that cells harbor virtually no free intracellular Cu underscores the ex-
istence of mechanisms for routing this essential metal while main-
taining minimal cytotoxicity. Two cytosolic Cu chaperones, Ccs1 and
Atx1 deliver Cu to Sod1 and the Ccc2 transporter localized to the
membrane of the secretory compartment, respectively. While weknow much about how Cu is loaded onto mitochondrial cytochrome
oxidase, the mechanism by which Cu is routed from the site of import
at the plasma membrane to the mitochondria is still largely unknown.
1.3. Ccs1–Sod1 copper relay
Ccs is widely distributed amongst eukaryotes where it is required
for delivery and insertion of Cu into Sod1. Ccs proteins harbor 3 do-
mains, two of which (domains II and III) are required for interaction
with and activation of Sod1. Within domain II lies a region of striking
homology to Sod1 that is responsible for Ccs1 docking onto Sod1. This
is followed by insertion of the Cu cofactor from Ccs1 into the active
site of Sod1 as well as the oxidation of an intramolecular disulﬁde
in Sod1, both required for its activation and mediated by Ccs1 Domain
III that contains a CXC Cu-binding motif. Comparatively less is under-
stood about Domain I, which, in addition to 2 cysteine residues at po-
sitions 27 and 64, also contains a CX2C motif shared by Atx1 and the
Ccc2 P-type ATPase Cu transporter. However, mutation of this motif
in S. cerevisiae does not appear to strongly impair Ccs1 activity in
vivo and, furthermore, is completely absent in S. pombe Ccs. Given
that Domain I is indispensible to Ccs function, it is thought that this
region may be required for interaction with Cu-ligands upstream of
Cu delivery to Sod1. Although there is a Ccs1-independent mecha-
nism of Sod1 activation, and several species lack Ccs1 altogether,
the Ccs1-Sod1 partnership in eukaryotes that express both proteins
is underscored by their matched intracellular localization that has
been detected in the cytosol, the mitochondrial IMS and in the nucle-
us. Ccs1 is imported into mitochondria via the Mia40/Erv1 disulﬁde
relay system that promotes the transport of cysteine-rich proteins
into the IMS. Although Ccs1 does not contain the twin CX3C or CX9C
domains that are required for substrate intermediate disulﬁde-
mediated interaction with Mia40, Domain I cysteine 64 interacts
with Mia40 to generate the disulﬁde intermediate [44]. Subsequent
disulﬁde bond transfer to Ccs1 occurs between cysteines 27 and 64
to form a stable IMS-localized Ccs1 protein that is competent in pro-
moting apo-Sod1 retention to this subcellular compartment by intro-
ducing Cu and the disulﬁde bond into TOM-translocated apo-Sod1.
1.4. Copper and the mitochondria
The small, hydrophilic protein, Cox17, was originally identiﬁed
from an S. cerevisiae cytochrome oxidase (CCO) assembly mutant
that was unable to carry out respiratory growth despite expression
of CCO components [45]. The observation that growth on non-
fermentable carbon sources could be rescued by Cu supplementation
indicated a role of Cox17 in delivering this metal to CCO or other tar-
get mitochondrial proteins. It is now known that Cox17 delivers Cu to
Sco1 and Cox11, two Cu-binding IM-associated proteins required for
the metallation and assembly of CCO. The localization of Cox17 both
to the cytoplasm andmitochondrial IMS, mediated by Mia40 interme-
diate formation via twin CX9C motifs on Cox17, initially suggested
that Cox17 delivers Cu from the cytosol to the mitochondria. Howev-
er, elegant experiments tethering Cox17 to the IM did not compro-
mise CCO biogenesis [46], indicating that Cox17 is competent to
access mitochondrial Cu stores for metallation of Sco1 and Cox11
and suggests that Cox17 does not ferry cytosolic Cu to the mitochon-
dria. At present, it remains unclear how Cu is delivered from its site of
entry across the plasma membrane to the mitochondria. It is possible
that an as yet unidentiﬁed Cu protein/ligand or transporter mediates
Cu shuttling to this organelle or perhaps, as an unexplored alternative
possibility, inter-organellar fusion between the secretory compart-
ment and mitochondrial tubules, that have been recently described
[47], allows for the passage of Cu into the mitochondria. It would be
interesting to evaluate mitochondrial Cu stores as well as respiratory
activity in S. cerevisiae strains lacking either Atx1 or Ccc2, both re-
quired for mobilization of Cu into the secretory compartment. In
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plementation that would bypass the Ccc2-dependent Fet3 mediated
iron uptake pathway.
1.5. Atx1–Ccc2 and the secretory compartment
A recent reviewon transitionmetal homeostasis in eukaryotesmade
the striking observation that the vast majority of the thirty or so known
Cu-binding proteins are predicted to be extracellular, underscoring the
critical importance for Cu mobilization into the secretory compartment
[48]. This notionwasﬁrmly established in S. cerevisiae atx1Δ strains that
are compromised in high afﬁnity Fe uptake due to the inability tometal-
late the multi-Cu ferroxidase Fet3 in the Golgi, leading to an inactive
Fet3–Ftr1 Fe oxidase-permease complex at the cell surface. Atx1 is a
small, cytosolic Cu chaperone with a ferredoxin-like fold and a Cu-
coordinating motif within its ﬁrst loop. This region shows high similar-
ity to the amino terminal metal-binding domains (MBD) of the Cu-
transporting P-type ATPase Ccc2, with which Atx1 transiently interacts
to deliver Cu for translocation into the secretory compartment. Copper
exchange between Atx1 and Ccc2 is dependent on the presence of at
least one of the two amino-terminal Ccc2 MBDs that not only receives
the cation for transport, but alsomitigates intra-molecular inhibitory in-
teractions between the amino-terminal domains and the active site of
the ATPase that allow subsequent delivery of Cu to the transport site.
Despite the atx1Δ mutant exhibiting a severe growth defect under Fe-
limiting conditions, the ccc2Δ strain is completely abrogated in ferrous
Fe uptake [49] evidencing the existence of an Atx1-independent mech-
anism of Cu delivery to Ccc2. Although the details of thismechanism re-
main elusive, it is likely not mediated by Sod1 or MTs, although the role
of Ccs1 in this process has not been addressed. Instead, studies revealing
the requirement for endocytosis as well as Ctr1 activity in Atx1-
independent Ccc2 Cu delivery raise the possibility that internalization
of Ctr1 into intracellular vesicles may contribute towards direct Ccc2
Cu delivery. Given the high degree of identity shared between the
MBD of Atx1 that receives Ctr1-internalized Cu and that of Ccc2, it is
possible that a similar mechanism of Cu relay to the Ccc2 MBD occurs
upon endocytic relocalization of plasmamembrane Ctr1 to intracellular
vesicles. Alternatively, perhaps glutathione–Cu+ coordination com-
plexes deliver Cu to Ccc2 in a manner similar to the CCS-independent
pathway for Sod1 [50].
1.6. The intracellular exchangeable copper pool and its storage
The dynamic changes in the cellular demand for Cu pre-empt
the existence of an exchangeable pool of intracellular Cu to allow
for critical biological processes in the face of a dramatic decrease
in extracellular Cu bioavailability. This reactive Cu pool is in part
maintained by the ubiquitous and abundant cysteine containing
tri-peptide, glutathione (GSH) that also plays a critical role in cellu-
lar ROS detoxiﬁcation [51]. Upon entry of Cu into the reducing en-
vironment of the cell, Cu+ spontaneously reacts with the internal
cysteine-SH of GSH and the Cu-GSH complex is thought to be
available to mediate Cu transfer to Cu-binding proteins within the
cytosol, the nucleus and the mitochondria, including the detoxify-
ing MTs, Atx1 and Sod1 [52,53]. In addition to cytoprotection
against Cu overload, yeast MTs, known to bind up to 8 Cu ions,
have also been proposed to mediate Cu transfer through direct in-
teraction with apo-metallo-chaperones, fulﬁlling both a role as a Cu
sink when Cu concentrations reach above the levels of cellular de-
mand as well as in its mobilization and delivery under conditions
of Cu scarcity [52].
Yeast cells utilize the vacuole as a dedicated organelle that, in ad-
dition to playing a critical role in maintaining intracellular pH, also
serves as a storage and sequestration compartment for amino acids,
metals and other metabolites. Evidence supporting the role of the
vacuole in Cu homeostasis arises from the observation that mutantsdefective in the biogenesis of this organelle display sensitivity to
high levels of exogenous Cu [54–56]. Although the mechanism of Cu
delivery to the vacuole is as yet unknown, mobilization of vacuolar
Cu stores into the cytosol is mediated by Ctr proteins, such as Ctr2
in S. cerevisiae and Ctr6 in S. pombe, the activities of which make Cu
available for Cu-chaperone-mediated intracellular distribution
[23,26,57]. In S. cerevisiae, the Fre6 metalloreductase acts in concert
with Ctr2 in vacuolar Cu mobilization [26], suggesting that vacuolar
Cu is mobilized to the cytosol as Cu+.
2. Copper in mammals: a fantastic voyage
The powerful genetics of yeast model systems has, to a large ex-
tent, led to the discovery of analogous mammalian genes and pro-
teins that carry out Cu metabolism. Despite the high degree of
structural and functional conservation of Cu metabolism proteins
between yeast and mammals (Fig. 1), mammalian orthologues are
primarily regulated via multiple post-transcriptional mechanisms,
rather than at the level of metal-responsive gene expression. A
major challenge faced by mammals in maintaining Cu homeostasis
is the integration of Cu sensing and mechanisms for ensuring sati-
ety beyond the level of the individual cell, within an organismal
context comprised not only of multiple cell types with unique cel-
lular demands for Cu, but also separated from each other by dis-
tance. This multi-dimensional regulation of Cu must efﬁciently
and correctly escort, deliver, and store the metal to cater for its de-
mand at the cellular, organ, and systemic levels. Furthermore, while
Cu is essential for the entirety of the mammalian life span and is
distributed throughout the body, speciﬁc developmental stages
and organs exhibit distinct demands for Cu that reﬂect their precise
physiological function or role in Cu storage. Indeed, while the liver
contains the highest steady state levels of Cu, followed by the brain,
heart and kidneys, muscle and bone display the lowest concentra-
tion of this metal. However, when taking into account the abun-
dance of these two tissue types in relation to the liver, Cu levels
in muscle and bone collectively account for approximately 50% of
the total amount of Cu in the body whereas the liver contains a
mere 10% [58]. Here, we will review current knowledge for how di-
etary Cu is acquired from the intestinal lumen, mobilized into the
portal circulation to the liver and subsequently systemically distrib-
uted to the peripheral organs.
2.1. Copper import into cells and tissues
Mammalian Cu acquisition, be it at the apical surface of intestinal ep-
ithelial cells or by cells located in the periphery, ismediated in large part
by the Ctr1 plasma membrane high afﬁnity Cu importer, a structural
and functional homologue of the yeast Ctr family of Cu importers. Con-
sistent with its functional activity in yeast, mammalian Ctr1-mediated
Cu import requires its prior reduction to Cu+ and, despite the lack of
formal identiﬁcation of the cell surface metalloreductase that fulﬁlls
this role, studies have demonstrated that members of the Steap family
ofmetalloreductases (Steap2, Steap3 and Steap4) can function as cupric
reductases in cultured cells, suggesting a physiological role in both Fe
and Cu reduction [59]. Mice systemically deleted for Ctr1 exhibit severe
growth and developmental defects and die in utero during mid-
gestation, evidencing the essentiality of this Cu importer, and for Cu,
in normal mammalian growth and development [60,61].
The regulation of Ctr1 activity occurs predominantly at the level
of transporter localization and abundance. Ctr1 is present at the
plasma membrane at times of cellular demand for Cu and on the
membrane of intracellular vesicles as a result of Ctr1 endocytosis
in response to elevated exogenous Cu [62,63]. Whether Ctr1 that
is localized to these intracellular vesicles functions to mobilize lu-
menal Cu to the cytosol, akin to the role we suggested for Ctr1 in
Atx1-indendent Cu delivery to Ccc2 in S. cerevisiae, is not currently
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cell models, and in mouse intestinal epithelium, to increase Ctr1
protein degradation [62,64].
An alternative mechanism for the uptake of Cu into mammalian
cells has been proposed that involves the transport of Cu–chloride
complexes by an anion exchanger [65]. However, conﬁrmation of
this observation awaits both the identiﬁcation of the anion exchanger
and demonstration that its genetic ablation in cells or animals results
in physiological Cu deﬁciency in vivo. In addition to Ctr1, Lee et al.
[66] reported that cells also possess another biochemically distinct
functional Cu transport activity with a lower afﬁnity that Ctr1 by ap-
proximately 10-fold. While this has yet to be identiﬁed, there is a pos-
sibility that the human counterpart to the recently identiﬁed Cu
importer Mfc1 in S. pombe, is responsible for this activity. Further-
more, new ﬁndings demonstrate that the human zinc importer Zip4
(Zrt- and Irt-like protein 4) expressed in Xenopus laevis oocytes trans-
ports Cu across a wide concentration range, raising the exciting pos-
sibility for a role of Zip4 in mammalian Cu transport [67].
A second Ctr protein, structurally related to Ctr1, has also been
identiﬁed in mammals and designated Copper transporter 2 (Ctr2).
Ctr2 harbors three putative transmembrane domains, is thought to
homo-multimerize and has conserved the Met–X3–Met motif in the
second transmembrane domain that is essential for Cu+ transport
by Ctr1. In contrast to the wealth of information regarding the struc-
ture, physiological function and mechanism of action of mammalian
Ctr1, comparatively little is known about that of Ctr2. Studies thus
far have suggested a role for Ctr2 in mammalian cells analogous to
the yeast vacuolar Ctr2/Ctr6 proteins in mobilizing Cu from intracel-
lular vesicles into the cytosol [68] or that Ctr2 functions as a low afﬁn-
ity Cu importer on the plasma membrane [69]. Recently studies have
shown that Ctr2 mRNA and protein levels decrease in the liver and
heart of Cu deﬁcient rats, which, a priori, would be inconsistent
with a role for Ctr2 as a Cu importer [70]. Furthermore, cells in
which CTR2mRNA has been knocked down by RNAi exhibit an overall
increased rate of macropinocytosis, suggesting that Ctr2 might also
function as a regulator of macropinocytosis [71]. Notwithstanding,
studies on the role of Ctr2 in mammalian Cu homeostasis have not
been reported in animal models and it remains unclear whether
Ctr1 and Ctr2 collaborate to regulate mammalian Cu acquisition. De-
ﬁnitive evidence regarding Ctr2 function in vivo currently awaits the
generation of systemic or tissue-speciﬁc knockout mice.
2.2. Copper chaperones in the cytoplasm
The intracellular relay of internalized Cu ions to the Cu-
dependent proteins and compartments for which it is destined fol-
low the same theme as we have outlined for yeast, with the transfer
of Cu to speciﬁc Cu chaperones and other ligands such as GSH or MT.
CCS is similarly required for Cu delivery to Cu,Zn SOD1 but unlike
yeast, cellular Cu status regulates CCS at a post translational level in-
volving the 26S proteasome in mammals, resulting in high protein
levels during Cu deﬁciency and low CCS levels during times of elevat-
ed intracellular Cu [72–74]. Although alterations in CCS expression
do not affect SOD1 protein levels, the activity of the enzyme changes
as a function of CCS (and thus Cu) levels [75,76]. Deletion of the CCS
gene in mice is not lethal, but impacts female fertility and reduces
SOD1 activity by 70–90% as well as protein levels in some reports,
[75–77]. This indicates that while CCS is critically important for
SOD1 activation, a CCS-independent pathway is in place to deliver
Cu to SOD1. Fascinating studies in C. elegans, which lacks CCS,
have demonstrated that this CCS-independent mechanism involves
Cu–GSH complexes [15,78].
Analogous to the Atx1-Ccc2 Cu relay and transport into the secre-
tory compartment, the orthologous mammalian chaperone Atox1
transfers Cu to the two Cu-transporting ATPases, Atp7a and Atp7b,
themselves orthologues of Ccc2. In mice lacking Atox1, reducedplacental Cu transport causes deﬁciency in both the brain and
liver of newborn pups, paralleled by reduced activity of the Cu-
dependent cytochrome oxidase and tyrosinase enzymes [79].
The Atox1−/− newborns also exhibit severely impaired growth and
perinatal viability, underscoring the critical role of Atox1 in Atp7a/
b-mediated Cu transport across the placenta and in systemic distri-
bution. Interestingly, in addition to its Cu-chaperone role in the cyto-
sol, it has been suggested that Atox1 also functions as a transcription
factor, translocating into the nucleus under conditions of high Cu and
stimulating the expression of the gene encoding extracellular SOD3
as well as other genes involved in cell proliferation such as cyclin
D1 [80,81]. Follow-up studies will be important to decipher the
mechanisms by which Atox1 regulation allows for these seemingly
mutually exclusive functions in delivering Cu to Atp7a/b for trans-
port into the secretory compartment or out of cells, and its accumu-
lation in the nucleus for transcriptional activation of target genes,
under high Cu conditions.
2.3. Mitochondrial copper escort
In mammals, the enzyme cytochrome c oxidase (CCO) (Complex
IV in the mitochondrial respiratory chain) is composed of 13 subunits,
ten of which are encoded by nuclear genes and three by mitochondri-
al genes. As described for yeast, Cu insertion into two of the
mitochondrially-encoded subunits, Cox1 and Cox2, is mediated by
the concerted action of several Cu-binding proteins, Cox17, Cox 11,
Sco1 and Sco2. Mice lacking Cox17 show impaired CCO activity and
die early in utero [82], demonstrating the critical importance of this
mitochondrial Cu chaperone. Supporting the importance of the Cu
binding subunits in CCO assembly, silencing of Cox17 in cell culture
reduces the steady state levels of Cox1 and Cox2 proteins as well as
CCO activity [83]. The two Sco proteins are responsible for receiving
Cu from Cox17 and loading two Cu atoms into the CuA site in Cox2.
Mutations in human Sco1 or Sco2 correlate with decreased tissue Cu
levels, decreased CCO activity and cause neonatal hepatic failure
and fatal hypertrophic cardiomyopathy [84–86]. In keeping with the
multiple proposed roles for Atox1, both Sco1 and Sco2 have been
demonstrated not only to be essential assembly factors for CCO, but
also to have regulatory roles in Cu homeostasis, particularly in the
regulation of cellular Cu export [87]. While these mitochondrial-
associated proteins clearly play a critical role in the assembly of CCO
and the insertion of Cu into speciﬁc subunits, it is currently unclear
how Cu travels from the site of import at the plasma membrane via
Ctr1 or other transporters, to the mitochondria and into the mito-
chondrial lumen.
2.4. Cellular copper detoxiﬁcation and storage
As Cu is an essential component in life that is neither created nor
destroyed, the ability to store excess Cu and to mobilize cellular Cu
stores during times of need is likely to be critical to the survival of or-
ganisms. While as we discuss below, the liver is thought to be a major
Cu storage organ in mammals, little attention has been paid to the
precise biochemical mechanisms by which metazoans store and mo-
bilize Cu, and the regulation of these processes. Perhaps we can glean
some preliminary insights into these processes from understanding
Cu detoxiﬁcation pathways, as these Cu-sequestering mechanisms
that function during times of Cu excess, may also have a physiological
role in Cu storage.
Mammalian metallothioneins (MTs) are small cysteine-rich poly-
peptides that tightly bind up to 12 Cu+ atoms through thiolate
bonds such that the Cu atoms are largely shielded from solvent. MT
expression is regulated at the transcription level by MTF1 (metal
transcription factor 1), which in response to elevated Cu levels accu-
mulates in the nucleus and binds the metal responsive elements
(MREs) in the promoter regions of its target genes [88]. MTs have
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chemical and toxicological perspective due to the rapid induction of
MT gene transcription in response to exposure to Cu and other
metals. While mice deleted for the MTI and MTII genes exhibit sensi-
tivity to Cd, Cu and other metals [89] it has also been proposed that
MTs contribute towards homeostasis under conditions of Cu limita-
tion [90]. In support of this, mouse embryonic ﬁbroblasts lacking
MT have reduced viability under Cu deﬁciency [91], suggesting a
role for MT as a storage protein for cellular Cu that could be mobilized
during times of Cu deﬁcit. Consistent with this notion, RNAi-mediated
knockdown of CCS induces the expression ofMT-I andMT-II genes, as
well as that of ATOX1, COX17 and ATP7A [92], suggesting that perhaps
the loss of abundant Cu binding proteins induces expression of other
Cu homeostasis proteins to protect cells against excessive amounts of
the metal.
How might Cu be mobilized if it is so tenaciously bound by
MTs? MT–Cu complexes are localized to lysosomes [93] and in rat
liver homogenates, MTs are partially degraded by lysosome-
associated enzymes, leading to the release of bound metals [94].
The acidic pH of the lysosome would favor displacement of metal
ions from MT and it has been proposed that an initial displacement
of metals is necessary to initiate the degradation of MT. Klaassen et
al. [94] also demonstrated that apo-MT degradation occurs much
faster than that of metal-bound MT, indicating higher holo-MT sta-
bility under conditions of metal excess. Lysosomal MT degradation
and Cu release raises the possibility that autophagy may play an ac-
tive role in Cu homeostasis. In line with this hypothesis, Nose et al.
[95] found that a single systemic injection of Cu into mice carrying
an intestinal-speciﬁc excision of Ctr1 not only rescued the perinatal
lethality of these mice, but also endowed these mutant mice with a
lifespan that is indistinguishable from wild type. These observations
suggest that a Cu bolus may be stored and efﬁciently recycled with
minimal loss or excretion.
Intracellular Cu has also been shown to be bound to GSH, albeit
with lower afﬁnity than to MT. In support of Cu-GSH representing a
potential pool of exchangeable Cu, experimentally depleted hepatic
GSH levels in Cu deﬁcient rats results in decreased Cu in the bile and
blood but increased Cu in the liver, suggesting that decreased GSH
levels may give rise to an oxidative environment in the liver that ren-
ders Cu less bioavailable [96]. An additional explanation for the high
hepatic Cu levels while hepatic GSH levels are low might be that GSH
plays a role in mobilizing hepatic Cu stores. Decreased GSH levels
have also been shown to inhibit the Atp7a/b Cu pumps, resulting in
cellular Cu accumulation [97]. Perhaps, as GSH functions in a CCS-
independent manner in loading Cu onto Sod1, GSH may also deliver
Cu to the cytosolic metal binding domains of the Atp7a/b Cu exporters
independently of Atox1. Alternatively, cellular redox state, inﬂuenced
by GSH levels, may be important for the function of Atp7a/b in Cu
export.
2.5. Copper export mechanisms
The two mammalian Cu+-transporting ATPases, Atp7a and
Atp7b, exhibit high sequence homology and, like the yeast Ccc2 pro-
tein, are responsible for the compartmentalization of Cu into the
lumen of the secretory compartment for its loading onto Cu-
dependent enzymes such as ceruloplasmin, tyrosinase, hephaestin
and other enzymes. Moreover, Atp7a and Atp7b play key roles in
exporting Cu from speciﬁc cells and in speciﬁc tissues, as a means
of driving vectorial Cu movement. For both the Cu export and Cu
compartmentalization functions, these Cu pumps are thought to pre-
dominantly receive their Cu cargo directly from the cytosolic Cu
chaperone Atox1. Although Atp7a and Atp7b pump Cu across mem-
branes via similar biochemical mechanisms, they are clearly not bi-
ologically redundant. Mutations in the ATP7A gene result in
Menkes Disease, characterized by an intestinal Cu block, peripheralCu deﬁciency and lethality typically by 2 or 3 years of age. Physio-
logically, Menkes disease manifestations are due to the inability to
pump Cu across the basolateral membrane of intestinal epithelial
cells to the periphery, or across the blood brain barrier, resulting
in a build up of intestinal Cu and inadequate supplies for Cu-
dependent enzymes in the periphery. Mutations in the ATP7B gene
cause Wilson's disease, characterized by excessive accumulation of
Cu in hepatic and neuronal tissues. Both Cu homeostasis disorders
present with severe neuromuscular, neuropsychiatric, and cognitive
defects, that, while arising from distinct etiologies, result from spe-
ciﬁc cell and tissue types where Atp7a and Atp7b function to move
Cu across membranes.2.6. Extracellular and circulating copper
In the bloodstream approximately 70–95% of total circulating Cu
is bound to the acute phase protein ceruloplasmin (Cp). Cp is a Cu-
dependent ferroxidase whose primary function is in loading Fe3+
onto transferrin for Fe distribution to the periphery. Given its abun-
dance and a Cu-binding stoichiometry of 6 Cu atoms per Cp mono-
mer, this protein was initially proposed to function in systemic Cu
transport, much akin to Fe-transferrin delivery to peripheral tissues.
However, ablation of the Cp gene in mice demonstrated that while
Fe homeostasis was severely impaired, Cu was delivered to periph-
eral tissues in a manner essentially indistinguishable from that of
wild type mice [98,99]. The half-life of holo-Cp is much longer
than the apo-enzyme, indicating that both Cp catalytic function
and protein stability are Cu-dependent [100]. Furthermore, recent
ﬁndings in Cu deﬁcient animals show reduced expression also of
the membrane bound splicing variant of Cp named GPI-Cp (glycosyl-
phosphatidylinositol- anchored Cp) [101]. GPI-Cp is a membrane
bound multicopper ferroxidase that is expressed in several cell
types and tissues [101,102].
In addition to GPI-Cp, two other membrane-bound multicopper
ferroxidases have been identiﬁed that include hephaestin and the re-
cently identiﬁed zyklopen [103]. Hephaestin is strongly expressed in
enterocytes where it is important for the export of Fe across the baso-
lateral membrane and into the portal circulation. Hephaestin protein
abundance is regulated by Cu status, with low Cu causing decreased
steady state levels of the protein [104,105]. Zyklopen has been sug-
gested to mediate placental Fe transport [103] but studies addressing
the full spectrum of the physiological roles of zyklopen have not yet
been reported. The critical role of the Cu-dependent ferroxidases in
Fe uptake and homeostasis imparts an intimate relationship between
Cu and Fe, whereby Cu deﬁciency leads to a secondary Fe deﬁciency.
Once in the circulation, Cu distribution to the periphery likely occurs
in a ligand-boundmanner, as free Cu is not well tolerated in biological
systems. Several low afﬁnity carriers have been suggested to trans-
port Cu in the blood, including macroglobulins and albumin
[106,107]. However, analbumenic mice show no critical effects on
Cu transport or homeostasis [108], suggesting that albumin is not
an essential Cu carrier under standard laboratory conditions. The gen-
eration of different macroglobulin knockout animal models will pro-
vide opportunities for further insights on the role of macroglobulins,
in systemic distribution of Cu.3. Copper homeostasis from an organ-speciﬁc perspective
Mammalian organs have distinct physiological functions and cell
types, reﬂecting diverse requirements for Cu and distinct contribu-
tions towards Cu homeostasis. To be able to fulﬁll these tasks, the lo-
calization and distribution of Cu transporters is distinct in different
cell types, as summarized in Fig. 2. Here we brieﬂy review key aspects
of Cu homeostasis in major organs.
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The journey of Cu through mammals begins at the apical mem-
brane of enterocytes within the lumen of the intestine. Here, dietary
Cu2+ is reduced and subsequently transported into enterocytes pri-
marily via Ctr1 localized on the apical membrane. Once inside, Cu
binds to ligands and proteins including GSH and intracellular chaper-
ones, and is routed to intracellular targets or pumped across the baso-
lateral membrane by Atp7a for peripheral distribution. During Cu
satiety, Atp7a localizes primarily to the membrane of the TGN, but
relocalizes to vesicles proximal to the apical and basolateral mem-
branes of enterocytes when Cu bioavailability increases, leading to
the transport of Cu into portal circulation [109,110].
Dietary Cu uptake depends on several factors including age, sex
and the amount of Cu in the diet. Mice carrying an intestinal-
speciﬁc Ctr1 excision display peripheral Cu deﬁciency, growth retar-
dation, hepatic Fe-overload, cardiac hypertrophy and die before
weaning [95]. Biotin labeling of Ctr1 in intact mouse intestine dem-
onstrated that in response to a Cu adequate diet, Ctr1 is found on
the apical membrane of intestinal epithelial cells and in intracellular
vesicles [64]. However, the majority of Ctr1 is localized to the apical
membrane in intestinal samples from mice reared on a Cu deﬁcient
diet, evidencing changes in Ctr1 localization as a function of dietary
Cu availability. The apical localization of mouse Ctr1 has also been
veriﬁed in other animal species, including rat and pig [64]. The ob-
servation that suckling mice exhibit higher Ctr1 expression at the
apical membrane of enterocytes when compared to older animals
supports the notion of age-speciﬁc differences in the systemic de-
mand for Cu [111], that is likely higher in younger animals due to
the presumably lower stores of this metal and to ongoing organ
maturation.
While multiple studies support the presence of Ctr1 at the plasma
membrane in cultured cells and the apical membrane in intestinal ep-
ithelial cell sections [64,111–113], another report suggests that Ctr1
does not localize to the apical membrane of enterocytes, but rather
to the basolateral membrane of cultured CaCo-2 cells and mouse in-
testinal sections [114]. This observation, and other studies, remain
to be reconciled. In addition to the role of Ctr1 in Cu transport from
the intestinal lumen, in vitro studies have also suggested that DMT1
(Divalent Metal Transporter 1) may contribute towards dietary Cu
uptake [115,116]. However the contribution of DMT1 to mammalian
Cu acquisition has not yet been fully validated in vivo, even though
in the Belgrade rat, a genetic model of Fe deﬁciency, expressing
high levels of an inactive form of DMT1, there is no evidence for al-
tered Cu transport or accumulation [117].
3.2. Hepatic copper storage, excretion and role in systemic
copper distribution
The liver is the main storage organ for Cu and other trace metals,
and consequently, is a central player in the regulation of systemic
Cu homeostasis. Primarily, the liver has four distinct responsibilities
when it comes to Cu homeostasis. It must store Cu, mobilize Cu to pe-
ripheral tissues, incorporate Cu into Cp and other Cu-dependent pro-
teins, and excrete Cu, when in excess of its storage capacity, into the
feces via the bile. Hepatic Ctr1 is localized to the basolateral mem-
brane of the hepatocyte and mediates Cu transport from the blood
into cells [111,118]. Mice with a liver-speciﬁc reduction in Ctr1 have
reduced activity of Cu-dependent enzymes, decreased Cu levels in
liver and kidney, and diminished Cu excretion through the bile
[119]. Cu levels in other organs were not reduced, suggesting the ex-
istence of a compensatory Ctr1-independent mechanism that facili-
tates uptake and/or enhanced systemic delivery of Cu from the liver
into systemic circulation, despite diminished Cu stores in this organ.
However, the molecular mechanisms by which this occurs remain
to be elucidated.Interestingly, the heart-speciﬁc excision of CTR1 that demonstra-
bly leads to low cardiac Cu levels and lethal hypertrophy, is accompa-
nied by an increase in the abundance of Cu in the serum. The export of
Cu from the liver into the blood is suggested by elevated serum Cu
levels concomitant with an increase in ATP7A expression at the
level of its mRNA and protein accumulation at cell surface of hepato-
cytes [120]. Moreover, Atp7a protein levels in intestinal epithelial
cells are elevated in parallel with hepatic Atp7a expression. While
this ﬁnding suggests a Cu-sensing mechanism by which the liver
and enterocytes respond to peripheral Cu deﬁciency by elevating
the levels of Atp7a in order to mobilize Cu stores, the mechanism by
which this signal is generated and interpreted are not yet understood.
Similar to the age-dependent localization observed for Ctr1 in in-
testinal epithelial cells [111], hepatic expression of mammalian
Atp7a diminishes during the life span of animals reared under Cu ad-
equacy during development from birth into adulthood [120,121]. This
is consistent with measurements of hepatic Cu stores, which reach a
maximum around birth and decline progressively thereafter
[120,122,123]. The positive association between Atp7a expression
and Cu levels in the neonate liver may relate to the suboptimal trans-
port capacities of the immature liver, resulting in limited export of the
metal to the periphery in young animals, or limiting hepatic stores to
meet higher developmental demands for Cu. Presently, it is not
known whether changes in hepatic Cu levels are solely correlated to
Atp7a expression or whether other as yet unidentiﬁed proteins are
also involved in sensing, mobilizing and sustaining the systemic de-
mand for Cu during different developmental stages and altered Cu
availability. Although, the observation that Cp levels in the serum
start off low at birth and thereafter rapidly increase at the same
time as hepatic Cu levels decrease [124], suggests that the rapid re-
duction in hepatic Cu concentrations after birth probably is caused
by several proteins.
In contrast to the perinatal expression of mammalian Atp7a, de-
velopmental maturity correlates with a predominance of Atp7b ex-
pression in the liver, responsible for pumping Cu into the secretory
compartment for metallation of Cp and other proteins and for the mo-
bilization of Cu into bile for excretion of excess Cu stores. In hepato-
cytes Atp7b is partially regulated by COMMD1 (Cu metabolism
Murr1 domain 1), which was ﬁrst discovered in Bedlington terriers
harboring a mutation in this gene that presented with hepatic Cu tox-
icosis [125]. Recent work shows that COMMD1 protein, in addition,
regulates SOD1 maturation and activity by reducing the level of
SOD1 homodimers [126]. The ﬁnding of COMMD1 also led to the dis-
covery of another hepatic protein involved in Cu homeostasis in the
liver, X-linked inhibitor of apoptosis (XIAP) [127]. Under conditions
of Cu excess, XIAP regulates its own protein stability through a nega-
tive feedback loop, the mechanism of which involves CCS-mediated
Cu delivery to XIAP, that primes it for proteasomal degradation via
auto-ubiquitination, and, in turn, the degradation of CCS through
XIAP-dependent poly-ubiquitination [128]. In contrast, when Cu
levels are low, apo-XIAP-mediated ubiquitination of CCS instead in-
creases CCS-mediated Cu delivery to SOD1, concomitant with elevat-
ed activity of this enzyme in the cell [129]. The precise mechanism for
the interaction between Cu and XIAP requires further elucidation, but
this discovery raises the possibility that aspects of the pathophysiolo-
gy observed during liver Cu toxicosis may result from reduced XIAP
expression and an increased sensitivity to apoptosis. Furthermore,
these ﬁndings underscore the possible role of ubiquitin/SUMO post-
translational modiﬁcations in modulating the abundance or activity
of other Cu dependent enzymes and proteins involved in cellular
and systemic Cu homeostasis or other processes in mammals.
3.3. Copper in the kidney
Given that circulating Cu is predominantly bound to Cp or seques-





























Fig. 1. Eukaryotic Cu homeostasis. A summary of the eukaryotic proteins involved in the sensing, acquisition, intracellular distribution andmobilization of copper (Cu). Each protein,
and its function andmode of action, are discussed in the text. The model to the left depicts the copper homeostasis machinery in S. cerevisiae, whereas the model on the right depicts

















































Fig. 2. Mammalian Cu homeostasis in select organs and cell types. Several organs where Cu homeostasis has been investigated are shown, including blood brain barrier, liver, placenta,
intestinal epithelial cells, kidney and heart. In the indicated cell types the membrane localization of Cu transporters and directionality are indicated. CSF, Cerebral Spinal Fluid.
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low, suggesting that urinary Cu excretion plays a minor role in sys-
temic Cu homeostasis under normal conditions. Ctr1 is expressed in
both proximal and distal tubular cells in the kidney and may import
glomerular-ﬁltered Cu from primary urine back into the blood
[111]. In support of this observation, Ctr1 levels in the kidney become
elevated under systemic Cu deﬁciency [111], which may serve to in-
crease the reabsorption of Cu from the urine. Curiously, the renal Cu
levels are refractory to Cu deﬁciency [95], suggesting that the kidney
at a higher degree than other tissues possesses mechanisms that
makes it more resistant to low Cu status. Atp7a and Atp7b co-
localize in both the proximal and distal cells of the cortical tubules,
however only Atp7a has been reported to relocalize to the basolateral
membrane during high Cu, possibly to protect renal cells from Cu tox-
icity by increasing the cellular export of Cu into the blood for storage
or excretion by the liver [130]. The generation of mouse models spe-
ciﬁcally deleted for Ctr1 or Atp7a/b in the kidneys would be a valu-
able tool with which to dissect the role of this organ and its
resistance to Cu lowering, as well as that of the Cu transporters, in
systemic Cu homeostasis.
3.4. Copper in the central nervous system
Much clinical and basic research data support the critical require-
ment for the tight regulation of Cu homeostasis in neurological devel-
opment and function [131,132]. The pathophysiology resulting from
both extremes of Cu availability notoriously manifests itself at the
level of diverse neurological impairments, which if left untreated,
lead to neuronal degeneration and death. There are several Cu depen-
dent enzymes that are crucial for appropriate neurological develop-
ment and function, including peptidylglycine-alpha-amidating
monooxygenase (PAM) that is important for the synthesis of ami-
dated neuropeptides and dopamine-beta-hydroxylase (DBH), that is
involved in production of norepinephrine, a critical neurotransmitter.
Ctr1 is highly expressed at the apical membrane of cells in the choroid
plexus that line the ventricular lumen as well as in endothelial cells of
the capillaries [111]. Under Cu deﬁciency, Ctr1 expression increases in
the choroid plexus, perhaps to facilitate the uptake of Cu from the ce-
rebrospinal ﬂuid required to meet the demands for this metal ion in
the brain [111,133]. In addition, CCS levels in the cerebellum increase
in Cu deﬁcient rat pups but those of CCS in the choroid plexus do not,
suggesting that there are distinct differences in Cu sensing, regulatory
responses or Cu-dependent activities in the choroid plexus versus
other brain regions [133]. Together, these ﬁndings stress the impor-
tance of the choroid plexus in the third and fourth ventricles for
maintaining Cu homeostasis in the brain.
Similar to ﬁndings in other tissues, the expression of Atp7a and
Atp7b in the brain changes during development, from embryonic
stages into adulthood. In the neonate, Atp7a can be readily detected
throughout the brain but decreases during development except in
cells of the choroid plexus and Purkinje neurons [134,135]. Atp7b is
similarly expressed in many regions of the brain, including the cere-
bellum and Purkinje neurons [136,137]. The ontogenic expression of
Ctr1, the P-type ATPase Cu transporters and perhaps other proteins
involved in Cu homeostasis in the central nervous system is an area
that is currently poorly understood. However given the striking neu-
rological pathologies associated with perturbations in Cu homeosta-
sis, this certainly represents an exciting and medically-relevant area
for future investigation.
3.5. The heart-felt requirement for copper
The demand for Cu in cardiac function is very high due to, among
other things, requirements for mitochondrial Cu-dependent ATP pro-
duction that drives cardiomyocyte contractility and the concomitant
elevated SOD1 activity needed to cope with the respiration-dependent generation of superoxide. The effects of Cu deﬁciency in
experimental animals have been recognized to cause cardiac hyper-
trophy, a pathological condition characterized by enlargement of car-
diomyocytes, which if left untreated leads to hypertension and
congestive heart failure. This pathophysiological manifestation of Cu
deﬁciency has been very clearly shown in several laboratories in dif-
ferent mammalian animal models [120,138,139].
In cardiomyocytes, Ctr1 localizes to the intercalated discs [111],
complex structures that connect single cardiomyocytes to an electro-
chemical syncytium that allows for the coordinated contraction of
myocytes along their entire length. In support of the high demand
for Cu by this organ, recent studies in a cardiac-speciﬁc Ctr1 knockout
mouse revealed severe Cu deﬁciency in the heart, growth retardation
and hypercardiomyopathy, leading to perinatal death [120]. This re-
capitulated the pathophysiology described in dietary Cu deﬁcient
humans and in animal models, but furthermore highlights the intrin-
sic requirement for Cu in the heart in the absence of effects resulting
from systemic deﬁciency. Interestingly, systemic ATP7A over-
expression in mice results in signiﬁcant depletion of Cu, particularly
in the heart [140], despite its fundamental role in dietary Cu uptake
and mobilization into the portal circulation. These ﬁndings under-
score the importance and differences in tissue-speciﬁc expression of
Cu-homeostasis proteins and the elaborate mechanisms at play in
achieving regulated systemic Cu metabolism.
The critical demands imposed by cardiac function require efﬁ-
cient ROS detoxiﬁcation mechanisms. Furthermore, access to reac-
tive cellular Cu stores to accommodate for ﬂuctuations in the
demand for and storage of excess Cu likely represent important
strategies for maintenance of cardiomyocyte function. Indeed,
cardiac-speciﬁc overexpression of MT in vivo has been reported to
increase cardiac Cu and Zn concentrations in mice and also protect
against Cu deﬁciency-induced cardiac hypertrophy [141]. These
ﬁndings propose that in the heart, MT proteins serve a dual role
in the safe sequestration of redox-active Cu as well as in maintain-
ing a store of this metal for use in times of Cu scarcity. How Cu
might be mobilized from MT during times of deﬁciency is an area
for further investigation.3.6. Placental copper exchange during pregnancy
During pregnancy the systemic demand for Cu increases to meet
the needs of the developing fetus and this correlates with an eleva-
tion of serum Cu levels. In the placenta Ctr1 has been localized at
the basal membrane, where it presumably serves to transport Cu
into syncytiotrophoblasts [142]. The localization of Ctr1 at the basal
membrane is somewhat unexpected as it suggests that Ctr1 trans-
ports Cu from the fetus into the placenta. However, circulating mater-
nal Cu levels are signiﬁcantly higher (approximately 5 times) than
those in cord blood [143], supporting a basal localization of Ctr1 to
favor transport of excessive Cu from the fetus to the mother rather
than in the opposite direction. In line with this, one may speculate
that the Cu levels in the fetus need to be extremely well regulated
due to immaturity of Cu binding enzymes, transporters, protection
against oxidative stress and shifting demands of Cu during different
periods of the embryogenesis. Atp7a and Atp7b are both expressed
in the human placenta tissue. However, as observed in other tissues,
these transporters perform distinct functional roles as inferred by dif-
ferences in their subcellular localization [144,145]. Speciﬁcally, while
Atp7a is responsible for the transport of Cu to the fetus, consistent
with its localization at the basal membrane, Atp7b localizes to the
apical membrane and that of the secretory compartment where it
may function in cellular Cu export and mobilization of the metal
into the Golgi for insertion into Cu-requiring proteins [145,146]. Fur-
ther studies on Cu homeostasis during pregnancy, and the inﬂuence
of hormonal responses, represent a promising ﬁeld for future
1590 T. Nevitt et al. / Biochimica et Biophysica Acta 1823 (2012) 1580–1593research, given the sub-optimal levels of Cu present in the typical
American diet [147].
3.7. Sensing peripheral changes in copper availability
Given the differences in Cu requirements as a function of develop-
ment, cell or organ type and dietary status, mechanisms must be in
place to sense and respond to overall body Cu status. Currently, very
little is known about systemic Cu signaling mechanisms. However,
in addressing the intrinsic role of Cu acquisition in cardiac function,
an interesting observation was made implicating the liver and intes-
tinal epithelium in responding to cardiac-speciﬁc Cu deﬁciency. This
study revealed that, while Cu levels remained unchanged in the vast
majority of organs and tissue types tested, there was a signiﬁcant re-
duction in liver-associated Cu accompanied by an elevation in the cir-
culating levels of the metal in the serum as well as elevated Atp7a
expression in intestinal epithelial cells and in the liver [120]. This
was interpreted as the possible mobilization of dietary and hepatic
Cu into circulation as a means to elevate its supply to distal organs,
such as the heart, experiencing a Cu deﬁcit. Although the mechanism
by which the liver or intestine sense inadequate Cu supply in a specif-
ic peripheral organ remains to be elucidated, it argues for the exis-
tence of a signal, perhaps synthesized or activated and secreted by
the afﬂicted tissue and sensed by the Cu acquisition and storage or-
gans. In support of this notion, human epithelial cells treated in
vitro with serum harvested from cardiac-speciﬁc Ctr1 knockout
mice strongly elevated Atp7a protein expression. The existence of a
metal-responsive regulator of systemic metal homeostasis is not a
new concept. Hepcidin is a small peptide hormone, synthesized pri-
marily by the liver under conditions of elevated Fe levels, that effec-
tively blocks Fe mobilization from the diet and hepatic stores under
conditions of Fe excess [148–150]. It is interesting to speculate that
a mechanism operates in mediating Cu homeostasis whereby a se-
creted factor serves as a signal to integrate the requirements of distal
organs and tissue types for this essential trace metal.
4. Concluding remarks
The last decades have witnessed phenomenal progress in our un-
derstanding of how cells transport and utilize Cu. Recent ﬁndings re-
vealing new aspects of how Cu homeostasis is regulated at the
multicellular organismal level have now paved the way for decades of
further investigations to elucidate the mechanisms by which cells and
organs communicate and coordinately cater for the changing develop-
mental and temporal demands for Cu over the life-time of the organism.
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